Executive and stakeholder communication turns technical results into decision material for boards, leadership teams, investors, corporate affairs, and external partners. Deliverables distil the question, the evidence, the options, and the trade-offs into clear narratives with supporting figures and tables. Materials are written in English for international use and designed to be read quickly without loss of scientific precision.
Work products include white papers for leadership, board and investment-committee briefings, investor and partner decks, Q&A documents, and external statements for corporate affairs. Messages are calibrated to internal policies and disclosure rules, with language that is specific, proportionate to evidence strength, and traceable to source. Public-facing statements align to regulatory positions and labeling (EU SmPC/PL with QRD; U.S. PLR), so regulatory and market narratives remain consistent. For devices, narratives note MDR/IVDR expectations and FDA device routes without overstating certainty. Disclosures are prepared to avoid selective release, with coordination to meet EU Market Abuse Regulation and U.S. Regulation Fair Disclosure requirements.
Each assignment begins with a defined objective, a target audience, and success measures. Source documents are organised into a citation-managed library, and a message map captures core assertions, supporting evidence, and limits of inference. Figures are built from verifiable data, numbers reconcile across text and graphics, and one-page executive summaries lead with the decision point and next steps. Where appropriate, plain-language summaries accompany scientific materials for non-technical audiences.
Risk and issues communication is handled with careful wording. Safety and uncertainty are stated explicitly when material to decisions. Forward-looking statements are separated from empirical findings and labelled for investor audiences. For sensitive topics, lines-to-take and brief talking points are prepared for senior spokespeople, with version histories preserved for audit. When external scrutiny is expected, a short backgrounder and an annex of primary references enable rapid verification by legal and corporate affairs.
Quality controls are embedded from scoping to sign-off. Terminology is harmonised, acronyms are controlled, and cross-references link narrative to tables and figures. Citations are validated against source metadata and supplied as a managed bibliography. Visuals follow accessibility basics with legible axes, units, and titles that state the takeaway. Draft one arrives on the scheduled date with tracked changes and a comment log explaining key decisions and references. One focused revision round is included to finalise the package.
Delivery formats include PDF briefing packs, editable slide decks, speaker notes, one-pagers, and copy for owned channels. Media lines or public statements are coordinated with legal and communications to maintain consistency with regulatory and investor materials. Handover includes speaker briefs and versioned files suitable for document control and distribution to senior stakeholders.
Assignments are executed in English for organisations across Europe and beyond. Contracting and invoicing can be arranged in CHF, EUR, NOK, or DKK.
For scoping, share the objective, the audience, the due date, required disclosure or regulatory constraints, and any existing messaging. A written statement of work will set the method, deliverables, schedule, and pricing as fixed or capped, with milestones aligned to internal governance.